Monitoring Physiological Variables with Membrane Probes by Janle, Elsa M.
112558
'L:__-_I
5 .'-..77
Monitoring Physiological Variables With Membrane Probes
FINAL REPORT
NAGW 4525
Principal Investigator: Elsa M. Janle, Ph.D
Bioanalytical Systems, Inc.
2701 Kent Avenue
West Lafayette, IN 47906
Phone: 317-463-4527
Fax: 317-497-1102
E-Mail: ejanle @bioanalytical.com
https://ntrs.nasa.gov/search.jsp?R=19970041366 2020-06-16T01:34:02+00:00Z
NAGW 4525 Principal Investigator: Elsa M. Janle
FINAL REPORT
NAGW 4525
Monitoring Physiological Variables With Membrane Probes
Principal Investigator: Elsa M. Janle, Ph.D
The microgravity conditions of space flight present the human body with an abnormal environment.
Responses to this altered environment can result in many physiological changes. In many cases, these
changes are undesirable and development of counter measures will enhance the well being and productivity
of humans in space. Study of physiology and development of counter measures may be hampered by the
small number of human subjects in space to study, and the undesirability of carrying out invasive
procedures on human subjects. Use of animal subjects also presents certain problems. There are a limited
number of subjects and a limited number of some types of samples because of the small size of the animal
In this project, we address some of the difficulties inherent in space physiological research involving
chemical measurements. Traditionally, the body fluids available for studying chemical changes have been
blood and urine. One of the major limitations in using blood, especially in small animals, is the limit of
samples which can be taken and the possibility of altering the physiology by removing large volumes of
blood. Additionally, blood chemistry represents an average of changes in the entire body. It does not allow
for characterizing specific changes within different tissues. The sampling devices and techniques that were
developed in this project offer solutions to a number of these problems. The sampling devices used were
membrane probes. The probes in this project were placed in subcutaneous and muscle tissue, however,
membrane probes can be developed for sampling any tissue. Two different types of probes were used
which operate either on the principle of ultrafiltration or microdialysis. The microdialysis probe does not
remove any liquid from the tissue but only chemicals which diffuse into the probe. The ultrafiltration probe
removes only interstitial fluid which is more easily replaced by the body than blood. These probes have an
additional advantage where they can be coupled with on-line sensors to provide real-time data acquisition.
In this project, we developed and tested two of these sensors: lactate and glucose.
Although many physiological systems and areas of space medicine could be investigated using these
devices and sampling techniques, two areas were explored in this project: electrolytes affected by
microgravity and the nutrients glucose and lactate which are important in muscle metabolism_
The methods developed in this project not only have the potential for facilitating both ground based and in
flight space research physiology, but may also be used to investigate and clinically monitor many human
diseases unrelated to space flight.
PROBE DEVELOPMENT
Both ultrafiltration (UF) and microdialysis (MD) probes were tested first in vitro and then in vivo. The
ultrafiltration probe consists of 3 hollow polyacrylonitrile (PAN) dialysis fibers, each 12 cm long (OD
320_tm, ID 220ktm). The thick wall of the fibers is necessary in order to prevent collapse of the fiber under
negative pressure sampling conditions. The fibers are formed into a loop and attached to 17" of FEP
microbore outflow tubing (OD 0.65 mm, ID 0.20mm) via a short (I cm) piece of polyurethane connecting
tubing (OD 1.5mm, ID 0.89mm). The microbore tubing can either be connected to a mini-peristaltic pump
or inserted into a hub assembly for use with a Vacutainer TM (Figure IA). In this study, the Vacutainer
system was used so that UF and MD samples could be collected simultaneously. Two configurations of
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microdialysis(MD)probeshavebeenconstructedforimplantationin twodifferentlocations.For
subcutaneousimplantation,a loopform(DL) hasbeenusedsothatimplantationcanbedonewithone
smallincision.ThesamePANmembraneusedin theUFprobewasusedin theMD probes.FortheDL
probe,fivecmof membranewasusedtomaximizerecoverywhilemaintainingultrafiitrationlossesatan
acceptablel vel(FigureIB).In thisprobe,eachendof thefiberwasattachedto 6" of FEPmicrobore
tubing(OD0.65mm,ID 0.125mm)usingthesamepolyurethaneconnectingtubingusedin theUFprobe.
Inordertomaintainapatentfluid pathwhenthefiberwasbentintotheloopconfigurationa0.003"316
stainlessteelwirewasplacedinthelumenof theprobe.Forsamplingfrommuscle,alinearmicrodialysis
probedesignwasdeveloped.ThisprobehasasmallerprofilethantheDLprobetoenableit tobethreaded
thoughmuscletissuewithaminimumof tissuedamage(Figure1C).Forthisprobe,1cmof membranewas
used.A pieceof polyimidetubing(OD0.216,ID 0.180mm)wasinsertedintothelumenof thePANfiber
andgluedinplace.A 102_mpolyesterfiberwasthreadedthroughthelumenof theprobe.It extended
beyondtheendof thepolyimidetubingandwasgluedatoneendoccludingthetubing.Thefunctionof the
polyesterfiberwastopreventkinkingof thefiberandasanaidfor implantation.Duringimplantationthe
polyesterfiberwasthreadedthroughaneedlewhichwasinsertedthroughthemuscle.Thefiberwasthen
pulledthroughthetissue.Theocclusionattheendof thetubingpreventedtissuefromenteringand
pluggingthetubing.Afterplacement,hefiberwasthreadedthrougha I cmpieceof PEEKtubing
designedto increasethediameterof thetubingtothestandardprobetubingsizeof .65mm.Thiswasglued
topolyimidetubingwithafewmmof thepolyimidetubingprotruding.Theoccludedendandfiberarecut
off witharazorbladeorscalpelcreatingtheflow-throughpath.A pieceof thisdiameter-increasingtubing
wasattachedto thedistalendbeforeimplantation,sincethisenddidnotneedtogothroughthetissue.
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Figure 1. The ultrafiltmtion probe consists of 3 hollow fibers attached to microbore tubing which can be
combined with a hub assembly for Vacutainer sampling (A). The DL microdialysis probe (B) was used for
subcutaneous sampling, while the linear microdialysis probe (C) was used for sampling from muscle.
NAGW4525 PrincipalInvestigator:Elsa M. Janle
IN VITRO RECOVERY
In vitro recovery is the first test of probe acceptability. Recovery refers to the amount of analyte obtained
through the probe membrane. There are two measures of recovery: Absolute Recovery and Relative
Recovery. Absolute recovery is the total amount of material removed from the system through the probe.
Relative Recovery is the concentration of the analyte in the solution obtained from the out flow of the probe
relative to the concentration in the solution or tissue being sampled. It is expressed as a percent. It is the
relative recovery which was determined in these in vitro tests. In order to provide valid data, the recovery of
an analyte with a probe must be great enough to provide a sample concentration which falls within the
assay sensitivity limits. In order to provide valid physiological data, the probe must have the same recovery
over the range of physiological and pathological concentrations being investigated.
Recovery is affected by a number of factors. Microdialysis recovery depends on membrane surface area,
chemical and physical characteristics of the membrane, temperature, the perfusion rate, sample matrix, and
chemistry of the analyte. Factors affecting ultrafiltration recovery are membrane characteristics,
temperature, sample matrix and chemistry of the analyte. Because of the sample matrix effect which is
present in both UF and MD sampling, it is not possible to directly extrapolate in vitro recoveries to in vivo
results. However, performance of in vitro recovery studies prior to in vivo studies are important to validate
that the analyte crosses the membrane and that there is no interaction of the analyte with the probe
materials. One can also get an indication of the concentrations to be expected and the sensitivity of the
analytical methods which will be needed.
All recoveries were done in an in vitro recovery station which was developed and constructed for this and
another NASA study (Figure 2). Since temperature affects the probe recovery, in vitro studies should be
done at the temperature at which the probes will ultimately be used. For in vivo studies this is usually 37 °
C. In order to prevent development of concentration gradients during the study, the solution should be
stirred. The in vitro recovery station had a heating, stirring unit with a well large enough to hold a 20 mL
scintillation vial. This container is a convenient size for in vitro recovery studies. The container is small
enough so that, if expensive analytes are being tested, excessive amounts are not required. It is large
enough so that concentration changes in MD and volume changes in UF do not significantly affect results.
The temperature of the in vitro recovery station is controlled by a BAS LC-22C Temperature Controller.
Illll t
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Pump
Fraction Temperature
Collector Controller
Figure 2. The in vitro recovery apparatus provides temperature control and stirring for the test solution.
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In this study, in vitro recovery was determined for sodium, potassium, chloride, glucose and lactate in
ultrafiltration. These are the analytes which were measured in the in vivo studies. Recovery studies were
done with ultrafiltration probes with three 12-cm fibers and DL microdialysis probes with 5 cm membrane
lengths. These are the same probes which were used in the in vivo studies. All studies were done in stirred
solutions at 37°C. Three concentrations of each analyte were tested. These concentrations represent the
range of possible normal physiological values and pathologically high and low values which might be
encountered in the in vivo studies. Table I gives the concentrations used in this study.
Table L Test concentrations for in vitro recover_'.
Analyte
Sodium
Potassium
Chloride
Lactate
Glucose
Low
1.10 meq/L
2 meq/L
70 meq/L
lmM
30 mg/dL
Normal
140 meq/L
4 meq/L
1O0 meq/L
5mM
100 m_/dL
High
180 meq/L
7 meq/L
130 meq/L
10mM
400 m /dL
Probes were presoaked in water overnight to wash off the glycerin coating. Three probes are tested in each
solution. The probes were then placed in fresh, distilled water in the recovery apparatus and held in place
with tubing clips. The UF probe was attached to the mini-pump (MF-5200) and pumped at a flow rate of
approximately 300 I,tL/hr. Perfusate was pumped through the DL probe using the BAS microdialysis
syringe pump (MF- 1001) and variable flow rate controller (MF- 1020) at a rate of 2 l,tl/min. For electrolyte
recovery studies, the perfusate was nano-pure water. For metabolites, the perfusate was Ringers' solution.
The probes were flushed for one hour and the collected samples were used as blanks. The probes were then
placed in the test solution. Four one-hour samples were collected. Test solution samples were collected
before the start of the recovery study and after each probe sample. Since the first sample was diluted by
the dead volume liquid from the flush samples, 2 to 4 were used to calculate recovery.
For each probe in each solution, the recoveries were calculated by dividing the concentration of the probe
sample by the average of the test solutions obtained immediately before and after the probe sample. This
compensated for any possible changes in test solution concentration due to evaporative losses or unequal
solvent and solute removal.
Figure 3 shows the recoveries for one UF probe in the three different glucose test solutions. The solution
labeled zero is the flush solution. The concentration of the analyte in this solution should be zero. If a non-
zero concentration were obtained it would indicate analyte carry over from a pervious study. Recoveries
from the first sample can sometimes appear low because of rinse solution left over in the dead volume of
the probe and tubing when the probe is switched from the flush to the test solution. Variations of recoveries
in samples 2 to 4 should be only random variations due to variability in assay method. Any significant
differences between samples 2 to 4 would indicate interaction of the test compound with probe materials.
Interactions of test compounds and probe materials could add a bias to the results.
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Figure 3. Recovery of one UF probe in solutions of three different glucose concentrations. Sample zero is
in saline solution with no glucose. At sample 1 the probe is placed into the test solution. Samples 2 to 4 are
used to calculate recovery for the probe.
It is desirable, but not absolutely necessary, that probe recoveries be the same in all probes of a given type.
Recovery studies can be done on individual probes before their intended use, but if one can be confident
that in vitro recoveries of all probes are the same, this step can be eliminated.
It is also necessary that recoveries be the same for a concentration range which spans the physiological and
pathological concentrations to be sampled during in vivo tests with these probes. Figure 4 shows the
sodium recovery for each UF probe for each concentration tested.
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Figure 4. Sodium recoveries for three UF probes at three concentrations spanning the range of
physiological and pathological concentrations. Recoveries are the same, within experimental error, for each
probe at each concentration.
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Foreachanalyte,two-wayANOVAswithout replication (¢x=5%) were done at each concentration on
eachprobe by sample, and on each probe for sample number by concentration. For sodium, glucose, and
lactate there was no significant effect of sample, probe, or concentration for ultrafiltration or microdialysis
probes at the p = 0.1 level. For potassium, there was no significant effect of concentration or sample for
ultraflltration or microdialysis probes, but there was a significant difference between probes. For chloride,
there was no significant effect of any of the factors in the analysis of the UF probes. For the MD probes,
there was no significant effect of sample or probe, but there was a significant effect of concentration.
Table II gives the overall recoveries for each probe type for each analyte tested.
Table II: In vitro recoveries.
Analyte
Sodium
UF-3-12 DL-5
94% + 5%
101% + 2%101% + 2%
Potassium 94% + 13% 106% -l-4%
Chloride 96% + 4% 95% + 7%
Glucose 99% + 3% 90% + 10%
Lactate 95% + 7%
These recoveries verified that the UF and MD probes were suitable for sampling these analytes in in vivo
studies.
One of the goals of this project, which was not completed, was to validate the use of UF and MD probes to
measure the certain hormones involved in water and electrolyte balance. The hormones selected were
Vasopressin, Aldosterone and ACTH. The recovery studies were done, but when the samples were assayed
the concentrations in both the probes samples and the original samples were low. These samples were
analyzed with commercial RIA kits from Diagnostic Systems Laboratories. Further work traced the
problem to a matrix effect of our samples. The assays were developed for plasma samples and MD and
UF samples having a different matrix. Developing assay methods for hormones in MD and UF samples
will need to be done as a separate research project. We are currently working with Diagnostic Systems
Laboratories to develop these methods and will submit separate proposals to accomplish the task.
Although valid concentrations could not be obtained from microdialysate and ultrafiltrate samples in the
recovery studies, the recovery could be calculated by relating the percent bound of the recovery samples
with that of the original solution. Using this method, the recovery of vasopressin in UF probes is estimated
to be about 91%. The recovery of aldosterone from UF probes was 96% and from MD probes was 26%.
Since these recoveries are high these probes will be able to be used to investigate hormone changes when a
RIA for ultrafiltrate and microdialysate samples has been developed.
ULTRAFILTRATION LOSSES FROM MICRODIALYSIS PROBES
Ideally, with the use of microdialysis probes there is no loss or gain in fluid volume of the perfusate passing
through the probe and the sample production rate is equal to the perfusion rate. In practice, there are often
changes in fluid volume. Water is a small molecule and can pass through the membrane if there is a
driving force. Loss of water from the perfusate to the tissue is referred to as ultrafiltration losses. The
most important factor controlling transfer of fluid from the probe to the tissue is a pressure differential.
This pressure differential is increased with increased flow rate and increased length of outflow tubing.
Ultrafiltration losses are also related to membrane length. The longer the membrane length, the greater the
ultrafiltration losses. Longer membrane lengths are frequently chosen to take advantage of the higher
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recoveries obtainable with larger probes. However, the advantages must be balanced with the disadvantage
of greater ultrafiltration losses. Characterization of a microdialysis probe involves evaluation of
ultrafiltration losses in both in vitro and in vivo studies.
The DL-5 microdialysis probes were tested for ultrafiltration losses during the recovery studies. Weighed
vials were used for the collection of samples. Perfusion rates were set at 2 l.tL/min. Individual probes were
used from one to five days. Overall ultrafiltration losses were 35.4% + 13.6%. The data was analyzed by
single factor ANOVA to determine if there were significant differences between probes and/or days of use.
There was a significant difference in UF losses between probes (Table [] ), but the differences between
days was not significant.
Table IlL ANOVA: Sin Factor:
SUMMARY
Groups (Days) Count Sum
1 24 8.643
2 17 5.99
3 16 5.512
4 2 0.713
5
ANOVA
2 0.736
Average Variance
0.360125 0.024488
0.352353 0.017045
0.3445 0.016297
0.3565 0.010805
0.368 0.022898
Source of Variation SS df
Between Groups 0.002795 4
Within Groups 1.114093 56
Total 1.116888 60
MS F P-value Fcnt
0.000699 0.035123 0.997569 2.536581
0.019895
ANOVA: Sinl_le Factor: Probes
ANOVA
Source of Variation
Between Groups
Within Groups
Total
SS
0.757985
0.358903
1.116888
df MS
24 0.031583
36: 0.00997
6G
F
3.167921
P-value
0.00088
F crit
1.824212
In vivo ultrafiitration losses were determined in three rats during the hind-limb suspension studies. Two-
hour samples were collected in weighed vials using a fraction collector. The flow rate was 2 gL/min. The
studies ranged from 2 to 25 days. The average in vivo uitrafiltration loss was 39% + 8%. Data was
analyzed by ANOVA. Slight differences between studies was obtained (Table IV). There were no
significant changes in ultrafiltration losses over time (Table V).
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Table IV. ANOVA: Single Factor: Suspension studies
SUMMARY
Groups
NASA 9
NASA 10
NASA 11
Count Sum
2 0.61
16 6.78
15 5.41
Average Variance
0.305 0.00125
0.42375 0.006745
0.360667 0.003307
_OVA
Source of Variation
3etween Groups
Within Groups
Total
SS
0.045433
0.148718
0.194152
df
30
MS
0.022717
0.004957
32
F
4.582473
P-value
0.01834
F crit
3.31583
Table V. ANOVA: Sinsle Factor: Time
_NOVA
Source of Variation
Between Groups
Within Groups
l'otal
SS df
0.064027 22
0.11425 8
0.178277 3G
MS
0.00291
0.014281
F
0.203787
P-value
0.998584
F crit
3.131277
ANALYTE ANALYSIS
Sodium was initially analyzed with the Cardy Compact Ion Meter (Horiba, Japan) for sodium (C-122) and
potassium was initially analyzed with the Cardy Compact Ion Meter for potassium (C131). These meters
were found to be lacking in the sensitivity necessary to observe the small changes in concentrations which
occur in living animals. Therefore, the alternative analytical procedures were investigated.
For sodium, a commercial combination ion selective electrode (MI-425, Microelectrodes, INC.) was used
with a voltmeter and a high impedance microelectrode adapter. This setup gave the needed sensitivity. For
potassium, a commercial ion selective electrode (MI-442, Microelectrodes, INC.) and reference electrode
(MI-402, Microelectrodes, INC.) with the same voltmeter and adapter setup as for sodium were used. This
system did not prove to be a stable system. The problem was traced to the reference electrode which was
filled with 3M KCL. Since the samples were measured on the order of 10 to 20 g.L, leakage from the
reference electrode was sufficient to continuously change the concentration of the sample resulting in an
unstable reading. The problem was solved by filling the reference electrode with 3M LiCI.
Chloride was analyzed spectrophotometrically using the Sigma Kit 461-3. A commercial ISE for chloride
was purchased from Lazar Research to correlate chemically-determined concentrations with electrode-
determined concentrations and to begin development of on-line determination. Lactate was analyzed using
the Sigma Kit 735-10. Glucose was analyzed by the BAS LC method using a glucose oxidase immobilized
enzyme reactor and a "wired" peroxidase electrode (1,2).
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EFFECT OF SIMULATED MICROGRAVITY ON ELECTROLYTES AND METABOLITES IN
THE RODENT MODEL
In order to simulate the fluid shifts of microgravity, a suspension system based on the BAS awake animal
system was developed for suspending the rats in a head down position. Rats were implanted with a DL-5
microdialysis probe, a UF-3-12 ultrafiltration probe, and a jugular catheter. The rats were placed in the
awake animal system and allowed to recover from anesthesia. Samples were collected from a baseline
control period of at least 3 days. Control periods varied because an attempt was made to begin all
suspensions at the beginning of a work week. This allowed for greater observation and possible adjustments
to the system at the beginning of the suspension. The rats were placed in a jacket and suspended for two
weeks. (In some cases, the suspension time was shortened because the rats were doing poorly.) The
suspension was then followed by a one week recovery period. Nine rats were used for this study.
Probe and Catheter implantation. Rats were anesthetized with a mixture of Ketamine and Xylazine.
Microdialysis and ultrafiltration subcutaneous probes were implanted as previously described (3). For the
implantation of linear muscle probes, a 1.5 cm incision was made in the skin of the hind leg, exposing the
muscle. The polyester internal fiber of the probe was inserted through the eye of a straight needle. The
needle was inserted through the muscle and the probe pulled into the muscle until the membrane window
was within the muscle tissue. Both ends of the probe were tunneled subcutaneously and exited at the base
of the neck. The incisions were closed and the occluded end of the probe was cut off forming a patent fluid
path.
Jugular catheters were implanted by isolating the jugular vein, making an incision into the jugular, inserting
the catheter, and suturing around the vessel and catheter. The catheter was then tunneled subcutaneously to
exit at the back of the neck close to the exit site of the UF and ME) probes. The catheter was tested for
patency, filled with the filling solution, and capped. A collar, with a tether line attached, is placed on the
rat, and the rat was placed in the awake animal system.
Catheter Development. Various modifications to the jugular catheter have been tried to develop long-term
vascular access. A polyurethane catheter with a heparin-lock (150 U/mL) can be maintained patent for 1
day. Increasing the heparin concentration to 500U/mL increased the patency to 7 days. Since the loss of
patency is probably due to the diffusion of the heparin lock out of the catheter and subsequent clot
formation, a less diffusible filling solution was tried. Filling the polyurethane catheter with Burr's solution
(4), a 9:1 glycerin:heparin mixture resulted in patency of 3 to 8 days. The disadvantage of this solution is
that it must be withdrawn from the catheter since the final concentration of heparin is 1000 U/mL the
solution. If blockage occurs, the catheter cannot be flushed to restore patency as it can with lower heparin
concentrations. In an attempt to develop a catheter, which will function for a longer period of time, we
tried working with a company, BSI, which coats catheters with heparin for human use. They prepared for
us 4 FEP, silicone, and polyurethane (Micro-Renathane®) heparin--coated catheters each. The FEP
catheters proved unsuitable because of lack of flexibility. The silicone catheters, when filled with saline,
had a patency of 3 to 4 days, which was not an improvement over non-coated catheters. When the filling
solution of the heparin-coated silicone catheter was changed to the Burr's solution, a patency of 17 days
was obtained in one catheter but only one day in another catheter. (In the 17 day case, the rat gained access
to the catheter and chewed it, so additional duration of patency may have been possible.) The heparin-
coated Micro-Renathane® polyurethane catheter patency ranged from 4 to 12 days.
Unfortunately, we were not able to pursue this avenue of catheter development further. BSI decided that
development of catheters for rats was of too small a commercial potential that they were unwilling to
prepare any additional catheters at any cost.
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Awake Animal System. The awake animal system (5) consists of a large round-bottomed containment bowl
for the rat and a table that fits over the bowl, which provides a point of attachment for a lever arm with a
two-channel swivel. The swivel is attached to the rat and allows the animal to move around freely while
providing for sample collection without the twisting of tubing. The perfusion pump is placed on the table
above the animal. Microdialysis samples were collected in a refrigerated fraction collector. Microdialysis
samples were collected for intervals of 120 minutes. Ultrafiltrate samples were collected with Vacutainers,
which were attached to the tether line and changed manually. Ultrafiltrate sample vials were changed
morning and evening except when there was a change in condition, such as anesthesia or suspension, in
which case the vials were changed when the change in condition occurred.
Suspension System: At the end of the control period the rat was placed in a jacket. Various modifications
were tested to dex;elop a secure system from which the animal could not escape. The most successful
configuration consisted of a full body jacket with two sWaps going around the hind legs to prevent escape
from the rear. A collar was placed on the animal and the jacket was attached to the collar to prevent escape
forward. The tether line was switched from the collar to the rear of the jacket to allow for suspension. The
table was raised 4 inches and additional counter weights were added to the lever arm in order to elevate the
rear end of the rat. The bowl was replaced with a rectangular container fitted with a wire grid, which
provided the rat with a surface to hole, allowing the rat to move around on it's front feet alone (Figure 5).
Figure 5. Awake animal suspension system used to simulate microgravity in the rodent model and study
effects on electrolytes and metabolites.
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SUBCUTANEOUS ANALYTE CONCENTRATIONS DURING CONTROL AND
MICROGRAVITY SIMULATION
Nine rats were used in the study of effect of microgravity on electrolytes and metabolites. Complete data
was not obtained on all rats. Different rats tolerated the stress of suspension differently. Two died during
suspension.
Average plasma and subcutaneous concentrations of analytes under different conditions are listed in Table
VI. Microdialysis probes are perfused with Ringer's Solution at 2 laldmin. Ringer's solution has the
following analyte concentrations: sodium, 147 meq/l; potassium, 4 meq/L; calcium, 4 meq/L; and chloride,
156 meq/L. Ultrafiltrate and microdialysis samples represent average concentrations over the period
sampled. Since ultrafiltration and microdialysis sampling are continuous, these concentrations represent
averages over the entire sampling period. Plasma concentrations on the other hand are instantaneous
values. Plasma values represent averages of single time points.
The probes were implanted under Ketamine-Xylazine anesthesia, which affects some analyte
concentrations. Therefore, baseline data collection is begun when the animal has fully recovered from the
anesthesia. The data in Table VI represent averages of all rats over the entire period of time under the
specified condition. There was, however, considerable variation between animals and there were also
changes during the treatments, especially the suspension and recovery periods. Data were analyzed using
the t-test to compare concentrations under different conditions.
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Sodium: In subcutaneous ultrafiltrates, sodium is slightly but significantly higher (_ -- .05, p = .046) than
baseline during anesthesia. Sodium is also slightly higher than baseline during suspension (or = .05, p =
.021). During the recovery period the sodium decreases to slightly below baseline levels (or = .05, p =
.046). In addition to obtaining average values for analytes under different conditions, the time course of
changes of the variables was examined. There is a high degree of variability between animals in some
analytes and in the responses to suspension and recovery. More detailed information about responses to
anesthesia, suspension, and recovery can be obtained from time courses rather than averages.
Figure 6 shows the time course of ultrafiltrate and plasma sodium changes in a individual rat during
baseline, suspension, and recovery. This rat was suspended on day l0 and recovery began on day 19.
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Figure 6. Ultrafiltrate sodium profile of one rat during baseline, suspension, and recovery.
There was minimal effect of anesthesia on sodium. One sample, on the day after anesthesia, was slightly
higher, which may have been due to a dehydration effect. Baseline values ranged between 133 and 135
meq/L. After suspension, sodium concentration initially decreased slightly below baseline concentrations
for 4 days, then rose above baseline concentrations for 3 days. The concentration returned to baseline
levels at the end of the suspension period. During the recovery period, the sodium concentration remained
at baseline levels.
The microdialysis averages show the same trends as the ultrafiltrate, with the anesthetized value higher
than baseline and the suspended average slightly higher than baseline, and during recovery the sodium
levels fell below baseline. Statistical analysis of the mierodialysis sodium concentrations did not show
significant differences. This is probably due to the fact that there is a greater variation in the microdialysis
data because each sample represents a shorter time period and concentrations can vary with water or food
consumption throughout the day. In this study the microdialysis samples were obtained over short intervals.
It is also possible to obtain ultrafiltration samples over short intervals, but at present, the only reliable
swivels available have only 2 liquid channels. Both channels are required for microdialysis sampling, and
therefore a choice must be made as to whether to do short interval microdialysis or ultrafiitration sampling.
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Microdialysiswaschosenbecauseit iseasiertointerfacewithon-linesensors,whichwerebeingdeveloped.
Figure7illustratesthevariationinmicrodialysatesodiumconcentrationsoverabaselineperiod.
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Figure 7. Microdialysis sampling was more frequent than ultrafiltration and therefore gives greater detail
of changes. This shows the variation in sodium in one rat during the baseline period.
One type of information available from these probes, which is not available from other sampling methods,
is the concentration in different tissues. Sodium concentrations of samples of ultrafiltrate and plasma, taken
simultaneously, were compared using a paired t-test. Subcutaneous ultrafiltrate sodium concentrations are
significantly lower than plasma sodium concentrations (ct = .05, p = .013). Microdialysis samples also
tended to be lower than plasma samples, but the difference was not significant. There were no significant
differences between ultrafiltration and microdialysis samples collected simultaneously.
Potassium: Subcutaneous potassium concentrations are slightly higher than baseline values, but the
difference is not statistically significant in either microdialysis or ultrafiltrate samples. Suspension results
in a decrease in average potassium concentrations. In microdialysis samples the difference is statistically
significant (a = .05, p < 0.0000). For ultrafiltration samples the difference is not statistically significant.
Figure 8 shows the subcutaneous ultrafiltrate in one rat during baseline, suspension, and recovery. In this
rat there was an immediate decrease in potassium following head down suspension. The potassium levels
began to shift back toward normal levels during the course of suspension, indicating a physiological
compensation mechanism was operating. During the recovery period, the concentrations stabilized
although concentrations were slightly lower than baseline.
There were insufficient plasma samples for statistical analysis; however, the trends are opposite to
subcutaneous concentrations. Plasma potassium is lower than baseline during anesthesia. Suspension
resulted in an increase in plasma potassium and there was no change during recovery.
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Figure 8. Subcutaneous ultrafiltrate potassium during baseline, head-down suspension, and recovery.
Potassium falls after suspension and then begins to return to normal.
Chloride: Anesthesia causes a slight increase in chloride concentration in subcutaneous tissue and in
plasma. Suspension in a head down position results in a decrease in chloride in both subcutaneous
microdialysis and ultrafiltration samples while plasma shows a slight elevation. During the recovery period
plasma remains unchanged, subcutaneous ultrafiltration showed an increase, and microdialysis a slight
decrease.
Lactate and Glucose: Glucose concentrations are increased in both subcutaneous tissue and plasma by
anesthesia. Lactate levels are less affected by anesthesia and show a greater variability between animals.
The average ultrafiltrate levels were lower, but the plasma and microdialysate levels were slightly higher.
Suspension increases the subcutaneous ultrafiltrate glucose levels as well as plasma lactate. During
recovery, subcutaneous glucose levels again decrease to baseline levels.
Muscle probe
Because of the small size of the rat muscle tissue a microdialysis probe must be used for sampling. Since
an ultrafiltration probe withdraws all of the fluid from the tissue itself, the volume of sample is limited by
the size of the probe. Insufficient sample would be obtained from an ultrafiltration probe to perform the
analysis. To sample from the muscle tissue a 1 cm probe was used. The probe was implanted as described
above and perfused with Ringer's solution. Two-hour samples were collected in a refrigerated centrifuge.
The samples were analyzed for sodium, chloride, lactate, and glucose. Figure 9 shows the time course of
these analytes in one rat under baseline conditions. Analyte concentrations fluctuate considerably under
baseline conditions. This may be related to muscle activity. The average level of glucose remains fairly
constant through the three day test period. Lactate, however, shows greater fluctuations. This may reflect
different levels of lactate production with different levels of activity. The average lactate concentration
declines over the course of the implant. Initial higher levels may be due to implant injury. Sodium and
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chloridealsoshowconsiderablevariation.Chlorideconcentrationsarehigherthansodiumbecausethe
chlorideconcentrationof theperfusateishigherthansodiumandbecauseof thesmallmembranesurface
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Figure 9. Analyte concentrations in rat muscle tissue. Microdialysis samples were obtained using a 1 cm
linear probe.
These probes demonstrate the possibility of monitoring from specific tissues in small rodents. Additional
work will be required to make the probes more durable. They were made with a narrow profile to cause
minimum damage, however, this also resulted in probes that were less rugged than the DL type probes. In
some cases, the membrane separated from the tubing. In other cases, the delicate nature of the probe tubing
resulted in a kink and thus an occlusion of the probe. It is currently possible to get several days of baseline
data with these probes, however, the probes cannot withstand the struggles of the rat when placed in a hind
leg suspension apparatus.
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DEVELOPMENT OF FLOW CELLS FOR ONLINE IN VlVO MEASUREMENT OF GLUCOSE
AND LACTATE
For the continuous monitoring of glucose or lactate, thin-layer cross-flow amperometric detectors with
enzyme modified working electrodes were developed. The enzymes glucose oxidase (GOX) or lactate
oxidase (LOX) were covalently immobilized in an osmium redox polymer film on the electrode surface.
The inlet and outlet tubing of the amperometric flow cell were compatible with the microdialysis tubing,
and the testing conditions for the detector, such as perfusion so|ution and flow rate, were typical of
microdialysis experiments..
The GOX electrode was prepared by coating the electrode surface with the enzyme and polymer mixture
solution followed by a cellulose acetate and Nation over-coating. The over-coating on the enzyme electrode
served as mass transport limiting membranes for better linearity. For the in vitro test of the glucose sensor,
the amperometric flow cell with the GOX electrode was perfused with standard solutions at 5/d,/min. The
average 0-90% rise time of the response was 2 min. The electrode gave a linear response to 0.1-20 mM
glucose concentrations, which covers the clinically relevant glucose concentrations. The electrode exhibited
poor sensitivity to glucose concentrations below 0.1 mM due to oxygen competition with the redox polymer
for GOX. After 72 hours of continuous use, the electrode lost 50% of its sensitivity. However, the
electrode was still usable and the linearity of the response did not change. Oxidase-based electrochemical
sensors used for analyses of biological fluid samples often suffer from various interferences such as
ascorbic acid, uric acid, and acetaminophen. In this study, the electrooxidation currents for artificial CSF
solutions containing 0.5 mM uric acid, 0.1 mM ascorbic acid, or 1 mM acetaminophen were measured with
a GOX electrode. The concentrations of these interferences shown above are close to their relevant
physiological concentrations except for acetaminophen, which for a worst case might be expected to be
about 0. I raM. The solution of uric acid did not show any electrooxidation current. There was an
oxidation current of 2 nA for the ascorbic acid solution. This current was equivalent to a 0.1 -ram variation
in the glucose concentration calculated from the calibration of the electrode. The electrode response to the
acetaminophen solution was 60 nA/mM so that a typical maximum response could be 6 hA, which was
equivalent to a 0.2-mM variation in the glucose concentration. Since the glucose concentration in most
biological samples is much higher than 0.2 mM, the interferences from both ascorbic acid and
acetaminophen should be tolerable.
The LOX electrodes were prepared similarly. The average 0-90% rise time of the response was 3 rain
when the perfusion solution at 5 gL/min was changed between different lactate standards. The electrode
gave linear responses to lactate from 0.1 mM to 5 mM and lost 50% of their sensitivities after 24 hrs of
continuous operation. The LOX electrode showed no responses to 0.5 mM uric acid and 0.1 rum ascorbic
acid solutions. However, it gave 233 nA/mM oxidation current for acetaminophen solution. Further
efforts are underway in our lab to eliminate the acetaminophen interference in the LOX modified
amperometric detector.
Because the cellulose acetate and Nation overcoating has poor reproducibility, we have recently replaced
the overcoating with a polycarbonate dialysis membrane. The dialysis membrane has shown a much better
reproducibility of the sensor. It also showed a better selectivity against interferents. We have also
explored the use of a disposable printed carbon electrode for the sensor development. Printed carbon
electrodes have many advantages over the conventional glassy carbon electrodes. These include low cost,
mass production, better quality control and disposablability.
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In Vlvo Sensor Tests
For testing the on-line sensors, DL subcutaneous probes were used because of their durability. The system
used for in vivo sensor tests was similar to previously described microdialysis systems, except that a liquid
switch was incorporated so that the sensor could periodically be switched from the animal to calibrating
solutions.
Sensors were calibrated daily before being connected to the animal. Sensors lost about 25% of activity
over a four day period. In order to increase analyte concentrations, intraperitoneal injections of glucose and
lactate were used. To decrease glucose levels, intraperitoneal injections of insulin were used. Figure 10
shows the output of the lactate sensor during baseline conditions and after injection of lactate. Figure 11
shows the glucose concentrations determined from the sensor output during a baseline period, after
injection of glucose to raise glucose levels, and after injection of insulin to lower glucose levels.
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Figure 10. Lactate sensor output during a subcutaneous DL probe during baseline conditions and after
intraperitoneal lactate injection.
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Figure 11. Glucose concentrations determined from the output of a sensor coupled to a subcutaneous DL
microdialysis probe during a baseline period, after injection of glucose to achieve an elevated glucose level
and after injection of insulin to lower glucose levels.
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Summary
This project has demonstrated the possibility of using membrane probes in rodents to monitor physiological
variables for extended periods of time. The utility of these probes in physiological studies of microgravity
has also been demonstrated. The feasibility of developing on-line sensors has also been .demonstrated and
allows for the possibility of developing real-time automated monitoring systems which can be used in
ground-base physiological research as well as in research and medical monitoring in space.
In addition to space applications these techniques can be extended to medical monitoring in critical care
situations on earth as well as facilitating research in many human and animal diseases.
References
I. Yang L, Janle E, Huang T, Gitzen J, Kissinger PT, Vreeke M, Heller A: Applications of "Wired"
peroxidase electrodes for peroxide determination in liquid chromatography coupled to oxidase
immobilized enzyme reactors. Anal Chem 67:1326-31, 1995.
2. Janle EM, Ash SR, Zopp WE, Kissinger P: Determination of glucose in microliter samples of in vivo
ultrafiltrates and microdialysates using amperometric flow injection analysis with an enzymatic reactor.
Current Separations 12:14-16, 1993.
3. Janle, EM: Implantation of Subcutaneous Probes in Rodents. Bioanalytical Systems Applications
Capsule 0241.
Brown DF and Burr RE, Customized Vascular Catheters for Rodents. Laboratory Animal Science, 35:
515-6, 1985.
Gitzen, J, Janle E, Buelher, E and Hampsch J. A Rodent Residence for In Vivo Bioanalytical
Sampling. Current Separations 13: 88-89, 1994.
.
.
INVENTIONS DEVELOPED UNDER CONTRACT NAGW 4525
• All devices and techniques developed under this contract were developed by Bioanalytical Systems, Inc.
There were no subcontractors.
• Sampling systems for small rodent microgravity simulations utilizing membrane probes.
• On-line lactate and glucose sensors for use with membrane probes.
Signature: £_ _ Date: /hy_
Elsa M.
Principal'Investigator
19
